Sorry. I meant to say "3,600 in May". Since LVCI's U.S. procedure count is growing more rapidly than international, and U.S. is now 89% of all LVCI procedures, this bodes well for LVCI's cash flow going forward. That analyst could indeed be very wrong, as analysts were with Visx.
Since May procedure count was 3,600 and average monthly count for April Q was 3,300, and 89% of procedures now U.S., it looks like June could be up to 3,900, and July 4,200 roughly speaking, and especially since a couple dozen contracts began since Jan 1, which are still young. So, maybe July Q procedures will be up 18% over April Q, to 11,700+/-, making EPS $0.10.
Any comments, anyone? |
